An expert calls for change in the way researchers and pharmaceutical companies collect and report adverse symptom information in clinical trials submitted to the Food and Drug Administration, and how the FDA represents this information on drug labels.
Patient safety reporting and drug label accuracy missing vital information, expert says
March 14th, 2010 by Newspublichealth.com
Leave a Reply
Sorry, no posts matched your criteria.